Showing results (371-380 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|April 7, 2018
Renal effects of non-tenofovir antiretroviral therapy in patients living with HIVMilena M McLaughlin, Aimee J Guerrero, Andrew MerkerDrugs in Context|April 26, 2018
Emollient treatment of atopic dermatitis: latest evidence and clinical considerationsKam Lun Hon, Jeng Sum Charmaine Kung, Wing Gi Gigi Ng, et al.Drugs in Context|April 21, 2018
Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in EuropeMontserrat Casamayor, Karen DiDonato, Marc Hennebert, et al.Drugs in Context|February 7, 2015
Resource use and outcomes associated with initiation of injectable therapies for patients with type 2 diabetes mellitusRichard Brice, Sharon Shelley, Pankaj Chaturvedi, et al.Drugs in Context|June 27, 2020
Neurological features of COVID-19 and their treatment: a reviewDaniele Orsucci, Elena Caldarazzo Ienco, Gianpaolo Nocita, et al.Drugs in Context|July 4, 2014
Study protocol for a randomized, controlled trial comparing the efficacy of two educational interventions to improve inhalation techniques in patients with chronic obstructive pulmonary disease (COPD): TIEPOC StudyJosé Leiva-Fernández, Francisca Leiva-Fernández, Rubén L Vázquez-Alarcón, et al.Drugs in Context|July 4, 2014
Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesJoshua J NeumillerDrugs in Context|July 22, 2022
Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reportsZoe Apalla, Marc Perrussel, Efstathios RallisDrugs in Context|July 22, 2022
Prazosin for the management of behavioural and psychological symptoms of dementiaRajesh R Tampi, Deena J Tampi, Syeda Arshiya Farheen, et al.Drugs in Context|March 17, 2023
High-rate breakthrough cancer pain and tumour characteristics - literature review and case seriesArturo Cuomo, Anastasios Boutis, Francesca Colonese, et al.Pageof 56